From the American Academy of Ophthalmology

From the American Academy of Ophthalmology

From the American Academy of Ophthalmology

The U.S. House of Representatives passed drug-compounding legislation Saturday that would provide little relief from access issues for ophthalmologists and their patients. Despite the advocacy efforts of the Academy and other physician associations, lawmakers passed a bill that excludes provisions negotiated in earlier House and Senate proposals to protect ophthalmologists’ access to office use of compounded drugs and products that have been repackaged. Under the House-passed bill:

American Academy of Ophthalmology

This mutlticenter study evaluated outcomes with the AT Lisa 909M diffractive multifocal toric IOL implanted in 284 eyes. At six months, 89.4 percent of eyes were within ±1.00 D of emmetropia. Mean refractive cylinder decreased from −2.39 D to −0.49 D. Distance, near, and intermediate vision were restored, allowing patients with significant levels of corneal astigmatism to achieve spectacle independence. Journal of Cataract & Refractive Surgery, October 2013